RSV Antibody Shot for Newborns Tied to Fewer Serious Bacterial Infections in a 530,000-Infant Study

A French study of nearly 530,000 infants links the RSV shot nirsevimab to fewer invasive pneumococcal hospitalizations. What it does not prove.

Have A Referral?